YS Biopharma(YS) - 2024 Q3 - Earnings Call Transcript

YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Conference Call April 19, 2024 8:00 AM ET Company Participants Alyssa Li - Director, Investor Relations David Shao - President & Chief Executive Officer Zenaida Mojares - Chief Medical Officer Brenda Wu - Chief Financial Officer Conference Call Participants Hunter Diamond - Diamond Equity Research Operator Ladies and gentlemen, thank you for standing by and welcome to YS Biopharma's Earnings Call for the First Nine Months of Fiscal Year 2024. [Operator Ins ...